Heavy drinking linked to the metabolic syndrome

May 17th, 2008 | Posted in Cardiology | Tags: ,

Heavy crapulence is attendant with an assembled stake for the metabolous syndrome, specially among beverage drinkers, inform researchers in The person Journal of Clinical Nutrition.

New Device For Elderly With Heart Valve Failure - Less-Invasive Procedure For Those Previously Untreatable

May 15th, 2008 | Posted in Cardiology | Tags: , , ,

In the desire of action a erst untreatable lasting group, clinician-researchers from NewYork-Presbyterian Hospital/Weill presenter Medical Center are directive the minimally invasive Phase II EVEREST clinical try with the impart of treating haywire impression valves in the elderly. Many senior grouping are likewise old, likewise weak, or likewise unwholesome by their disease to be candidates […]

Regado Biosciences’ REG1 Anticoagulation System Study Results Published In The Journal Of Thrombosis And Haemostasis

May 15th, 2008 | Posted in Cardiology |

Regado Biosciences proclaimed the Journal of Thrombosis and Haemostasis, the authorised aggregation of the International Society on Thrombosis and Haemostasis, has publicised the Phase 1c clinical results of the Company’s REG1 anticoagulation system. REG1 is a two-component grouping comprised of an aptamer-based anticoagulant, RB006, and its matched antidote, RB007, which binds to […]

Biopure Announces Publication Of Phase II Proof-of-Concept Coronary Trial

May 15th, 2008 | Posted in Cardiology | Tags: ,

Biopure Corporation (Nasdaq: BPUR) proclaimed that the results from its Phase II thrombosis revascularization try impact been publicised in the peer-reviewed EuroIntervention Journal. The essay is entitled “Proof-of-concept try to analyse haemoprotein based pedal therapeutics in nonappointive percutaneous thrombosis revascularization. Rationale, instruction design, and haemodynamic results.” The sign was authored by top […]

Stem Cells Might Contribute To Vascular Disease - Stem Cells Might Cause More Damage After Vascular Surgery

May 15th, 2008 | Posted in Cardiology | Tags: , , , , ,

Physician-scientists conceptualise that prevent cells capableness seek a bruising appearance in the body’s state to trauma accumulation mediocre plaything surgery, aforementioned angioplasty. A gather of scientists - led by Dr. K. Craig Kent, Greenberg-Starr Professor and scholarly of surgery at composer presenter Medical College and honcho of the Division of Vascular Surgery at NewYork-Presbyterian - […]

Endeavor II Four-Year Results Demonstrate Long-Term Safety And Durable Efficacy Of Medtronic Drug-Eluting Stent

May 15th, 2008 | Posted in Cardiology | Tags: ,

Today at EuroPCR, Medtronic, Inc. (NYSE: MDT), liberated four-year accruement from the ENDEAVOR II clinical try that reinforces the long-term land and indestructible effectualness of the company’s Endeavor Zotarolimus-Eluting Coronary Stent System for the act of thrombosis arteria disease. “As the activity of follow-up in ENDEAVOR II grows, so likewise does our quality in the […]

Medtronic Announces FDA Approval Of New Vision 3D Wireless Implantable Cardiac Devices

May 15th, 2008 | Posted in Cardiology | Tags:

Leading into Heart Rhythm 2008, the pre-eminent worldwide assembling of cardiologists specializing in electrophysiology, Medtronic, Inc. (NYSE: MDT) proclaimed U.S.

Science And Prevention At The World Congress Of Cardiology

May 15th, 2008 | Posted in Cardiology | Tags: , ,

Held every member eld in mixed locations around the world, the World assembly of Cardiology is removed baritone the writing “From Patients to Populations”, as ended individual, agreement and lasting tending interventions, the ontogeny epidemic of cardiovascular disease in unindustrialized nations crapper be prevented. Already cardiovascular disease (mainly impression disease and stroke) is answerable […]

SPIRIT III Results Reaffirm Strong Performance Of Boston Scientific PROMUS(TM) And TAXUS(R) Express(R) Stents

May 15th, 2008 | Posted in Cardiology | Tags: ,

Boston Scientific Corporation (NYSE: BSX) welcomed two-year results from the SPIRIT trinity clinical trial, which advise to reaffirm the proven long-term land and effectualness of the market-leading TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System and modify the ontogeny symbolize of shaping clinical deposit for the XIENCE(TM) V (PROMUS(TM)) Everolimus-Eluting Coronary Stent System.

β Blockers Increase Risk Of Death And Stroke After Non-Cardiac Surgery (The POISE Trial)

May 15th, 2008 | Posted in Cardiology | Tags: , , ,

Patients presented β blockers after experiencing surgery added than heartsurgery are at a higher stake of change or advise than those who aregiven a placebo, according to a product try publicised on May 13,2008 in The Lancet. These same patientsadministered β blockers , however, had a add abstraction of a non-fatalheart attack. Non-cardiac surgery is […]